Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)

The National Institutes of Health (NIH) is seeking revision applications from currently funded NCI P50 specialized centers to incorporate novel NCI-supported technology and accelerate cancer research. The goal of this funding opportunity is to promote interdisciplinary collaboration and accelerate the development of innovative tools and methods for cancer research. • The applicants should propose to expand upon original research questions or accelerate progress for the parent study by incorporating a new technical approach or device developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. • Awards from this funding opportunity are meant to incentivize independent validation and accelerate the suitability of emerging technologies for research communities. • The estimated funding for this opportunity is $150,000, and the award ceiling is also $150,000. • The application deadline is October 3, 2025.